Eli Lilly And Co vs Silicon Motion Technology Corporation American Depositary Shares — how do they compare? Eli Lilly And Co trades at $1,214 (market cap $1.04T), while Silicon Motion Technology Corporation American Depositary Shares trades at $220.06 (market cap $8.36B). The key difference: Eli Lilly And Co is far larger — about 124.4× Silicon Motion Technology Corporation American Depositary Shares's market cap, and Silicon Motion Technology Corporation American Depositary Shares pays the higher dividend (0.81%). Which is the better fit depends on your goals — on Pluang, investors hold Eli Lilly And Co for 94 Days and Silicon Motion Technology Corporation American Depositary Shares for 0 Days on average.
| LLY | SIMO | |
|---|---|---|
Market Cap | $1.04T | $8.36B |
Volume | 1,843,375 | 663,682 |
Sector | Health | Technology |
52-Week High | $1.28K | $336.90 |
52-Week Low | $799.57 | $80.16 |
Typical Hold Time | 94 Days | 0 Days |
Enterprise Value | $1.09T | $8.35B |
Dividend Yield | 0.59% | 0.81% |
Signals from Pluang's Aura AI — not financial advice
Eli Lilly (LLY) trades at $1,211.40, up 2.43% today, with a bullish technical outlook and strong fundamentals. The company reported robust earnings beats in recent quarters, with Q2 2026 EPS of $8.38 surpassing the $6.40 estimate. Revenue surged to $65.18 billion in 2025, driving a net income margin of 33.53%. Positive news flow highlights pipeline advancements in weight-loss drugs, including EloraTZP's promising trial results.
Outlook remains positive given dominant market position in obesity and diabetes treatments, with analyst consensus price target of $1,350 implying ~11% upside. Key risks include competitive pressures from Novo Nordisk and regulatory hurdles. Earnings growth and pipeline catalysts support further appreciation, though high valuations warrant monitoring.
Silicon Motion (SIMO) trades at $246.63, down 0.13% on the day, with technical indicators showing neutral signals. The company demonstrates strong fundamentals with Q2 2026 EPS beating expectations at $2.43 versus $2.13, and revenue growth projected to reach $1.3B in 2026. Analyst sentiment remains overwhelmingly positive with 81% buy ratings and a consensus price target of $356.25, representing 44% upside potential from current levels.
The outlook for SIMO appears favorable given accelerating enterprise storage demand and AI infrastructure expansion. Key risks include semiconductor cycle volatility and competitive pressures in NAND controllers. With robust profitability metrics including 31.6% ROE and expanding margins, the stock offers growth exposure to the AI storage market, though investors should monitor execution on Q3 2026 earnings expectations of $3.3 EPS.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Latest headlines on both assets
Eli Lilly is a drug firm with a focus on neuroscience, endocrinology, cancer, and immunology. Lilly's key products include Verzenio for cancer
Read more on LLY →Silicon Motion Technology Corporation designs and develops NAND flash controllers for solid-state storage, with flagship SSD, eMMC, and UFS controller products, including its Ferri-branded automotive and industrial storage solutions, used by OEMs and NAND flash makers worldwide.
Read more on SIMO →